Clinical trial
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye…
NCT00025818 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00025818 |
|---|---|
| Title | Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Keratoconjunctivitis Sicca, Sjogren's Syndrome, Lupus Erythematosus, Systemic, Arthritis, Rheumatoid, Scleroderma |
| Intervention type | Drug |
| Interventions | Ophthalmic Emulsion |
| Enrollment | 290 |
| Start date | May 1, 2001 |
| Primary completion | Mar 1, 2003 |
| Completion | Mar 1, 2003 |
| First posted | Oct 29, 2001 |
| Last update posted | May 30, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: